Download PDF
Thromb Haemost 1994; 72(01): 092-097
DOI: 10.1055/s-0038-1648818
Original Article
Schattauer GmbH Stuttgart

Different Regulation of Plasminogen Activator Inhibitor 2 Gene Expression by Phorbol Ester and cAMP in Human Myeloid Leukemia Cell Line PL-21

Kenji Niiya
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
,
Taketoshi Taniguchi
2   Medical Research Laboratory, Kochi Medical School, Nankoku, Kochi, Japan
,
Masahiro Shinbo
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
,
Tai-ichi Ishikawa
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
,
Shigeki Tazawa
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
,
Yumiko Hayakawa
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
,
Nobuo Sakuragawa
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
› Author Affiliations
Further Information

Publication History

Received 24 September 1993

Accepted after resubmission 01 March 1994

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Previous studies have shown that protein kinase C (PKC) activators and dibutyryl cyclic AMP (Bt2cAMP) synergistically increase the antigen level of plasminogen activator inhibitor type-2 (PAI-2) in a human myeloid leukemia cell line PL-21. To clarify the mechanism, PAI-2 gene expression induced by phorbol myristate acetate (PMA), a PKC activator, and Bt2cAMP was investigated by Northern blot hybridization using a PAI-2 cDNA probe cloned from a human placental library. The level of PAI-2 mRNA was markedly increased in response to PMA and reached a maximum 5-9 h after stimulation. Nuclear run-on assay revealed an increase in PAI-2 gene transcription in PMA-treated cells. The induction was inhibited by inhibiting de novo protein synthesis with cycloheximide (CHX). cAMP also increased PAI-2 mRNA level in a dose-dependent manner. The increase began within 2 hours and, contrary to the case of PMA, the mRNA levels were maintained. Moreover, cAMP-induced increase in PAI-2 mRNA was not inhibited by CHX, rather enhanced. PMA and cAMP synergistically induced PAI-2 gene expression, which was completely inhibited by CHX. The cells pretreated with PMA for 24 h did not any more respond to stimulation with PMA but responded to cAMP and PAI-2 mRNA level was increased. The apparent half-life of constitutive level PAI-2 mRNA in PL-21 cells, determined by actinomycin-D-decay experiments, was approximately 2 h. Those induced by PMA and cAMP were approximately 5 h and 2 h, respectively. These data suggest that PAI-2 mRNA induced by PMA is relatively stable and the expression requires de novo protein synthesis, whereas cAMP increases PAI-2 mRNA level without affecting the stability and the induction does not require de novo protein synthesis. Judging from these data, PAI-2 gene expression appears to be differently regulated by the PKC and cAMP signalling pathways.

 

  • References

  • 1 Carrell R, Travis J. α2-antitrypsin and the serpins: Variation and countervariation. Trends Biochem Sci 1985; 10: 20-24
    CrossrefPubMedGoogle Scholar
  • 2 Kruithof EKO, Vassalli J, Schleuning W, Mattaliano RJ, Bachmann F. Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem 1986; 261: 11207-11213
    PubMedGoogle Scholar
  • 3 Alving BM, Krishnamurti C, Liu YP, Lucas DL, Wright DG. Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60. Thromb Res 1988; 51: 175-185
    CrossrefPubMedGoogle Scholar
  • 4 Medcalf RL, Van-den-Berg E, Schleuning WD. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. J Cell Biol 1988; 106: 971-978
    CrossrefPubMedGoogle Scholar
  • 5 Johnson SE, Baglioni C. Positive and negative regulation of a tumor necrosis factor response in melanoma cells. J Biol Chem 1990; 265: 6642-6649
    PubMedGoogle Scholar
  • 6 Rehemtulla A, Arndt A, Hart DA. Induction of plasminogen activator inhibitor type 2 expression during differentiation of human K562 cells towards a macrophage phenotype. Biochem Cell Biol 1990; 68: 1337-1343
    CrossrefPubMedGoogle Scholar
  • 7 Takeuchi T, Niiya K, Kubonishi I, Miyoshi I. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the car-boxy-terminal chain of plasminogen activators. Thromb Haemost 1990; 63: 259-264
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Kubonishi I, Ohtsuki Y, Miyagi T, Yoshimoto S, Akagi T, Miyoshi I. Electron microscopic and immunohistochemical observations of differentiation of human myeloid leukemia line, PL-21. J Cancer Res Clin Oncol 1986; 111: 203-208
    CrossrefPubMedGoogle Scholar
  • 9 Aihara H, Asaoka Y, Yoshida K, Nishizuka Y. Sustained activation of protein kinase C is essential to HL-60 cell differentiation to macrophage. Proc Natl Acad Sci USA 1991; 88: 11062-11066
    CrossrefPubMedGoogle Scholar
  • 10 Stone RM, Weber BL, Spriggs DR, Kufe DW. Phospholipase C activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood 1988; 72: 739-744
    PubMedGoogle Scholar
  • 11 Sherman ML, Stone RM, Datta R, Bernstein SH, Kufe DW. Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. J Biol Chem 1990; 265: 3320-3323
    PubMedGoogle Scholar
  • 12 Genton C, Kruithof EK, Schleuning WD. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol 1987; 104: 705-712
    CrossrefPubMedGoogle Scholar
  • 13 Medcalf RL. Cell-,and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system. J Biol Chem 1992; 267: 12220-12226
    PubMedGoogle Scholar
  • 14 Antalis TM, Dickinson JL. Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells. Eur J Biochem 1992; 205: 203-209
    CrossrefPubMedGoogle Scholar
  • 15 Cousin E, Medcalf RL, Bergonzelli GE, Kruithof EK. Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 1991; 19: 3881-3886
    CrossrefPubMedGoogle Scholar
  • 16 Niiya K, Takeuchi T, Kobayashi M, Miyoshi I, Hayashi T, Sakuragawa N. Dexamethasone and phorbol ester, but not cytokines, increase the production of plasminogen activator inhibitor type-2 in the PL-21 human promyelocytic leukemia cell line. Thromb Haemost 1991; 66: 232-238
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Hayashi T, Niiya K, Hirokawa S, Sakuragawa N. Synergistic stimulating effect between cyclic AMP and phorbol ester on plasminogen activator inhibitor type 2 production in human promyelocytic leukemia cell line PL-21. Biochim Biophys Acta 1992; 1134: 273-277
    CrossrefPubMedGoogle Scholar
  • 18 Sambrook J, Fritsh EF, Maniatis T. Molecular Cloning, A Laboratory Manual (Second Edition). 1989; 7: 7.39-7.52
    PubMedGoogle Scholar
  • 19 Sambrook J, Fritsh EF, Maniatis T. Molecular Cloning, A Laboratory Manual (Second Edition). 1989; 7.19-7.22
    PubMedGoogle Scholar
  • 20 Ye RD, Ahem SM, Le-Beau MM, Lebo RV, Sadler JE. Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin. J Biol Chem 1989; 264: 5495-5502
    PubMedGoogle Scholar
  • 21 Webb AC, Collins KL, Snyder SE, Alexander SJ, Rosenwasser LJ, Eddy RL, Shows TB, Auron PE. Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibi-tor.J Exp Med 1987; 166: 77-94
    PubMedGoogle Scholar
  • 22 Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 1984; 311: 433-438
    CrossrefPubMedGoogle Scholar
  • 23 Heller R, Bussolino F, Ghigo D, Garbarino G, Schroder H, Pescarmona G, Till U, Bosia A. Protein kinase C and cyclic AMP modulate thrombin-induced platelet-activating factor synthesis in human endothelial cells. Biochim Biophys Acta 1991; 1093: 55-64
    CrossrefPubMedGoogle Scholar
  • 24 Saceda M, Knabbe C, Dickson RB, Lippman ME, Bronzert D, Lindsey RK, Gottardis MM, Martin MB. Post-transcriptional destabilization of esterogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J Biol Chem 1991; 266: 17809-17814
    PubMedGoogle Scholar
  • 25 Medcalf RL, Kruithof EKO, Schleuning W-D. Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. J Exp Med 1988; 168: 751-759
    CrossrefPubMedGoogle Scholar
  • 26 Pytel BA, Peppel K, Baglioni C. Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor. J Cell Physiol 1990; 144: 416-422
    CrossrefPubMedGoogle Scholar
  • 27 Bergonzelli GE, Kruithof EK, Medcalf RL. Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3′,5′-monophosphate. Endocrinology 1992; 131: 1467-1472
    CrossrefPubMedGoogle Scholar
  • 28 Cohen RL, Niclas J, Lee WM, Wun TC, Crowley CW, Levinson AD, Sadler JE, Shuman MA. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation. J Biol Chem 1989; 264: 8375-8383
    PubMedGoogle Scholar
  • 29 Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984; 308: 693-698
    CrossrefPubMedGoogle Scholar
  • 30 Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 1988; 54: 541-552
    CrossrefPubMedGoogle Scholar
  • 31 Nakabeppu Y, Ryder K, Nathans D. DNA binding activities of three murine Jun proteins: stimulation by Fos. Cell 1988; 55: 907-915
    CrossrefPubMedGoogle Scholar
  • 32 Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 1988; 55: 917-924
    CrossrefPubMedGoogle Scholar
  • 33 Boyle WJ, Smeal T, Defize LH, Angel P, Woodgett JR, Karin M, Hunter T. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 1991; 64: 573-584
    CrossrefPubMedGoogle Scholar
  • 34 Binetruy B, Smeal T, Karin M. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 1991; 351: 122-127
    CrossrefPubMedGoogle Scholar
  • 35 Ohsawa K, Hyakawa Y, Nishizawa M, Yamagami T, Yamamoto H, Yanaihara N, Okamoto H. Synergistic stimulation of VIP/PHM-27 gene expression by cyclic AMP and phorbol esters in human neuroblastoma cells. Biochem Biophys Res Commun 1985; 132: 885-891
    CrossrefPubMedGoogle Scholar
  • 36 Fink JS, Verhave M, Walton K, Mandel G, Goodman RH. Cyclic AMP-and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J Biol Chem 1991; 266: 3882-3887
    PubMedGoogle Scholar
  • 37 Comb M, Bimberg NC, Seasholtz A, Herbert E, Goodman HM. A cyclic AMP- and phorbol ester-inducible DNA element. Nature 1986; 323: 353-356
    CrossrefPubMedGoogle Scholar